Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Second-Generation Atroposelective Synthesis of KRAS G12C Covalent Inhibitor GDC-6036
Jie Xu, Ngiap‐Kie Lim, Jacob C. Timmerman, et al.
Organic Letters (2023) Vol. 25, Iss. 19, pp. 3417-3422
Closed Access | Times Cited: 15

Showing 15 citing articles:

Atroposelective catalysis
Tanno A. Schmidt, Valeriia Hutskalova, Christof Sparr
Nature Reviews Chemistry (2024) Vol. 8, Iss. 7, pp. 497-517
Closed Access | Times Cited: 15
Chemical Process Development in the Pharmaceutical Industry in Europe—Insights and Perspectives from Industry Scientists
Joachim I. Krueger, André P. Dieskau, Jorma Hassfeld, et al.
Angewandte Chemie International Edition (2025)
Open Access
Chemical Process Development in the Pharmaceutical Industry in Europe—Insights and Perspectives from Industry Scientists
Joachim I. Krueger, André P. Dieskau, Jorma Hassfeld, et al.
Angewandte Chemie (2025)
Open Access
Development of a Streamlined Manufacturing Process for the Highly Substituted Quinazoline Core Present in KRAS G12C Inhibitor Divarasib
Johannes A. Burkhard, Sebastian Herold, Christian Leitner, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 1, pp. 102-111
Closed Access | Times Cited: 4
Targeting the EGFR/RAS/RAF signaling pathway in anticancer research: a recent update on inhibitor design and clinical trials (2020–2023)
Rima Hajjo, Dima A. Sabbah, Sanaa K. Bardaweel, et al.
Expert Opinion on Therapeutic Patents (2024) Vol. 34, Iss. 1-2, pp. 51-69
Closed Access | Times Cited: 4
Synthesis of a Highly Functionalized Quinazoline Organozinc toward KRAS G12C Inhibitor Divarasib (GDC-6036), Enabled through Continuous Flow Chemistry
Sean M. Kelly, René Lebl, Thomas C. Malig, et al.
Organic Process Research & Development (2023)
Closed Access | Times Cited: 9
Scalable Synthesis of 6-Chloro-1H-pyrazolo[3,4-b]pyrazine via a Continuous Flow Formylation/Hydrazine Cyclization Cascade
Thomas M. Bass, Daniel Zell, Sean M. Kelly, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 7, pp. 2635-2645
Closed Access | Times Cited: 2
Manufacturing Process for 6-Bromo-N,N-bis(4-methoxybenzyl)-4-methyl-5-(trifluoromethyl)pyridin-2-amine, a Key Intermediate in the Synthesis of KRAS G12C Inhibitor Divarasib
Jeff Shen, Nicholas A. White, Qingping Tian, et al.
Organic Process Research & Development (2023) Vol. 28, Iss. 1, pp. 92-101
Closed Access | Times Cited: 6
Nucleic Acid-Based Approaches to Tackle KRAS Mutant Cancers
Jimi Kim
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 23, pp. 16933-16933
Open Access | Times Cited: 3
Fit-for-Purpose Synthesis of a KRASG12C Covalent Inhibitor, via a Diastereoselective Hayashi Arylation
Carmela Molinaro, Nicholas Wong, Nicholas A. White, et al.
Organic Process Research & Development (2024) Vol. 28, Iss. 8, pp. 3313-3325
Closed Access
Covalently targeting KRAS G12C
Matthew R. Janes, Lian‐Sheng Li, Rasmus Hansen, et al.
Elsevier eBooks (2024), pp. 147-171
Closed Access
Discovery of novel tetracyclic quinazolines as multi-KRAS inhibitors for the treatment of solid tumors
Chang‐Hee Hong, Jooyun Lee, Dowon Kim, et al.
Bioorganic & Medicinal Chemistry Letters (2024), pp. 130087-130087
Closed Access
Binding modes of the KRAS(G12C) inhibitors GDC-6036 and LY3537982 revealed by all atom molecular dynamics simulations
Renne Leini, Kari Kopra, Tatu Pantsar
(2023)
Open Access | Times Cited: 1
Analysis of the Structural Transformations Underlying the Design of Innovative Next-in-Class Drugs
Konstantin V. Balakin
Russian Journal of General Chemistry (2023) Vol. 93, Iss. S2, pp. S401-S425
Closed Access | Times Cited: 1
Scalable Synthesis of KRAS G12C Inhibitor GDC-6036
Dirk Trauner, Xiang Ji
Synfacts (2023) Vol. 19, Iss. 08, pp. 0833-0833
Closed Access
Page 1

Scroll to top